Anacetrapib

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameAnacetrapib
Drug Alias Name安塞曲匹Anacetrapibum阿西曲匹MK-0859
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHDL-cholesterol stimulantsCholesteryl ester transfer protein inhibitors
TargetsHDL-cholesterolCholesteryl ester transfer protein
Therapy Area/IndicationsSitosterolemiaHomozygous familial hypercholesterolemiaHypercholesterolemia +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesSweden +[10] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesMerck Sharp & Dohme CorpUniversity Of OxfordMerck Sharp & Dohme LLC +[4] 
Inactive CompaniesMerck Sharp & Dohme (China) Co Ltd
Active IndicationsHypercholesterolemiaDyslipidemiasAtherosclerosis +[4] 
Inactive IndicationsSitosterolemiaHomozygous familial hypercholesterolemiaHyperlipidemias +[5] 

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG